Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
3(33%)
Results Posted
25%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
4
44%
Ph phase_1
1
11%
Ph phase_2
1
11%
Ph phase_4
1
11%
Ph phase_3
2
22%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting2
unknown1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 21 (11.1%)
Phase 32 (22.2%)
Phase 41 (11.1%)
N/A4 (44.4%)

Trials by Status

unknown111%
completed444%
terminated111%
recruiting222%
active_not_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9